Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Designer Drugs MeSH Descriptor Data 2026


MeSH Heading
Designer Drugs
Tree Number(s)
D26.909.500
Unique ID
D015198
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D015198
Annotation
coordinate with specific drug or chemical; do not confuse with DRUG DESIGN
Scope Note
Drugs designed and synthesized, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are MPTP (a reverse ester of meperidine), MDA (3,4-methylenedioxyamphetamine), and MDMA (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines.
Entry Term(s)
Customized Drug
Customized Drugs
Designer Drug
Registry Numbers
0
Previous Indexing
Chemistry, Pharmaceutical (1984-1988)
Street Drugs (1985-1988)
See Also
Illicit Drugs
Substance-Related Disorders
Public MeSH Note
1989
History Note
1989
Date Introduced
1989/01/01
Last Updated
2020/05/27
Designer Drugs Preferred
page delivered in 0.133s